Communiqués NovAccess Global Inc.

Actions

XSNX

US67001N1072

Temps Différé OTC Markets Autres places de cotation 19:25:53 27/06/2024			Varia. 5j.	Varia. 1 janv.
0,01 ^USD	+25,00%		-5,66%	-50,25%

21/05	NovAccess Global Inc. dépose un brevet auprès de Cedars-Sinai pour faire progresser sa plateforme de vaccins contre le cancer du cerveau	CI
17/05	NovAccess Global Inc. (OTCPK:XSNX) a acquis 18,60% des parts de Fendix Media Ltd auprès de David Sumner pour 0,12 million de dollars.	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

NovAccess Global : Material Agreement Form 8 K	04/06	PU
NovAccess Global : Announces New License to Advance its Immunotherapy Platform	30/04	PU
NovAccess Global Announces $10.7 Million Financing	03/01	AQ
NovAccess Global Inc. to Present at the December 7th Virtual Investor Summit	01/12	NE
NovAccess Global Partners with BCN Biosciences to Expand Immunotherapy Platform	28/07/23	AQ
NovAccess Global : to Participate in National Brain Tumor Society’s Annual Glioblastoma Awareness Day	13/07/23	PU
NOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	23/06/23	AQ
NOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	12/06/23	AQ
NovAccess Global Lead Scientist Published in High-Profile Medical Journal for Cancer Vaccine Advancements	12/05/23	AQ
NovAccess Global : Lead Scientist Published in High-Profile Medical Journal for Cancer Vaccine Advancements	11/05/23	PU
NOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	02/05/23	AQ
NOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	18/04/23	AQ
NOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities (form 8-K)	16/03/23	AQ
NovAccess Global : Dr. Christopher Wheeler, NovAccess Lead Scientist, Receives Prestigious Golden Axon Award	15/03/23	PU
NovAccess Global to Present at World Orphan Drug Congress	17/02/23	AQ
NOVACCESS GLOBAL INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	14/02/23	AQ
NOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	13/02/23	AQ
NovAccess Global Leadership to Present at World Brain Mapping Foundation Annual Congress	06/02/23	AQ
NovAccess Global : Material Agreement - Form 8-K	24/01/23	PU
NOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	23/01/23	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués NovAccess Global Inc.

Actions

XSNX

US67001N1072

Communiqués

Filtres